Ebixa® memantine
Ebixa 10 mg tablet is on the approved list in
the Netherlands.
It is possible to order Ebixa ® 10mg on
prescription through a reliable source, Meerburg Pharmacy.
Axura®/Namenda®/Ebixa® are different brand names
of the same medicine.
Ebixa® fax order form  (Acrobat)
Ebixa® fax order form
(Word 2002)
Ebixa's European approved indication is in the treatment of moderate severe to
severe Alzheimer's disease.
Voice Mail call back service: US toll free (1)
877 839 2664.
Patient Information
Patient
information leaflet in English 
(wait to download)
Prospecto
(Español)
Notice
(Français)
Prescribing Information
In English
(wait to download)
En
Español
En
Français
Namenda
® USA prescribing information
(wait to download)
Ebixa is available for international importation
on patient label.
Important Notice
Meerburg Pharmacy neither promotes nor encourages the use and importation
of medications in any way.
Each country has its
own laws and regulations for the importation of medication to protect
their citizens.
e.g. USA: http://www.customs.gov/xp/cgov/travel/alerts/medication_drugs.xml
e.g. Australia: http://www.health.gov.au/tga/docs/html/bringmed/persimp.htm
e.g. Canada (EN): http://www.hc-sc.gc.ca/hpfb-dgpsa/inspectorat/imp_hum_drug_per_use_enf_dir_tc_e.html
e.g. Canada (FR): http://www.hc-sc.gc.ca/hpfb-dgpsa/inspectorat/imp_hum_drug_per_use_enf_dir_tc_f.html
Ordering requirements:
Ebixa® is available for international shipment.
Before ordering Ebixa ® it is important that you
read the package leaflet
and discuss any questions you might have with your doctor. Your caregiver
may be able to assist you with any details you wish to discuss.
If Ebixa® is not approved in your country
yet, it can be
dispensed in situations where a patient cannot be treated suitably with approved
medication:
- The specialist has thorough experience in the
treatment of Alzheimer's disease and is well aware of the therapeutical indications, contra-indications,
precautions, drug interactions and side effects of Ebixa® and has informed the
patient that this medication is unapproved (informed consent);
for example see below*)
- The doctor declares that he is aware that Ebixa®
is not on the approved list and that no effective alternative treatment is
available domestically
(no approved alternatives); for example
see below *)
- The patient declares that Ebixa® is for own use and
provide the name and address of the qualified doctor (in your country)
responsible for evaluation of the treatment with Ebixa® (declaration);
(on order form)
- If you meet the above mentioned conditions and
you have a valid prescription, you
can order Ebixa®
Meerburg Pharmacy will
guarantee that the recipient will receive the
Ebixa
medication or else no charges will be made.
We cannot be
responsible for knowing all aspects of the taxes and duties which may be
applied in the country to which we are shipping. In some cases, duties and
taxes may be as much as as 75% of the total value of the shipment (India).
Some countries levy VAT on personal importation . Those costs are the responsibility
of the recipient.
| *)
Example of doctors declaration:
This
doctor’s declaration must show your name and date of birth. Your
doctor may choose his own words and must use his
letterhead. An example:
To
whom it may concern:
This
is to certify that I have prescribed the drug Ebixa for my patient
________________, DOB _________.
I
realize that this medication is not available in __________ and that
is classified as an investigational drug. I have informed my patient
of this fact and have discussed with him the possible drug
interactions and side effects which could occur. My patient will be
under my constant care while she is taking this medication.
Should
you have any further questions for me do not hesitate to contact me.
Sincerely,
______________
, M.D.
|
Ordering procedures and prices:
Prices, product information, procedures and conditions
of shipment are specified on our order forms.
You can order Ebixa 10mg tablets either online, by fax or by mail. Initial
prescriptions and doctor's letters can be faxed to our (US-toll free) fax
number (1) 877 839 2664.
Meerburg Pharmacy recommends you to use
our electronic
order form to prevent errors. However we have a fax order form with
all information; We suggest you to print the fax
order form for a (3 page)
overview with all relevant information. All
prices on our order forms include FedEx International Priority
shipment.
Fax/Mail order form with procedures and prices (print this out for
reference):
Ebixa® fax order form (Acrobat)
Ebixa® fax order form
(Word 2002)
Order forms for liquid (drop) presentation are available
on request
Electronic order forms:
Ebixa®
secure online order form 
SSL 128 bit secure
If you get an error, your browser might not support 128 bit secure data transmission.
Please adjust your browser or select the standard form instead.
Ebixa®
standard online order form
standard security
Email service: I
have specific questions about Ebixa = Memantine (click here)
Voice Mail call back service: US toll free (1)
877 839 2664.
Scientific Publications :
Other information:
Information about memantine from the Alzheimer's Association Fact Sheet:
Memantine is a drug developed by the German company Merz + Co. for treatment of symptoms of dementia. The drug has been approved in Germany for more than 10 years, where it is marketed by Merz under the trade name
Axura®.
In May 2002, the European Union's Committee for Proprietary Medicinal Products approved memantine for treatment of
moderately severe to severe Alzheimer's throughout the European Union, where it is marketed by Lundbeck as Ebixa®.
Memantine appears to protect the brain's nerve cells against excess amounts of glutamate, a messenger chemical released in large amounts by cells damaged by Alzheimer's disease or certain other neurological disorders. The attachment of glutamate to cell surface "docking sites" called N-methyl-D-aspartate (NMDA) receptors permits calcium to flow freely into the cell, which in turn may lead to cell degeneration. Memantine may prevent this destructive sequence by adjusting the activity of glutamate.
Memantine's action in the glutamate system differs from the activity of the cholinesterase inhibitors that are currently approved in the United States for treatment of Alzheimer's. Cholinesterase inhibitors temporarily boost levels of acetylcholine, another messenger chemical that becomes deficient in the Alzheimer brain. These differing modes of action raise the possibility that individuals may be able to take memantine either as stand-alone therapy or in combination with cholinesterase inhibitors.
|
|
|
Drug for Late Stages of Alzheimer's Is Approved
By THE ASSOCIATED PRESS
 ASHINGTON,
Oct. 17 — The Food and Drug Administration on Friday approved a new option
for people with Alzheimer's disease, the first treatment specifically for
late stages of the illness.
The drug, memantine, has long been sold in Germany, and many people in
the United States have bought it over the Internet.
Now that memantine has been approved, Forest Laboratories
will sell it in the United States under the brand name Namenda for patients
with moderate to severe symptoms of Alzheimer's. The company said the drug
should be on pharmacy shelves in January.
Memantine does not offer miraculous benefits. The drug agency's
scientific advisers, in evaluating it last month, worried that memantine's
availability could give false hope to families of the most severely ill.
In studies, some patients who took memantine have experienced
improvements in memory and thinking skills. But for the vast majority, the
drug merely slows the pace of deterioration, letting patients maintain
certain functions a little longer.
The nation's four other Alzheimer's medications — Aricept, Exelon, Reminyl and Cognex — work in the early stages of the disease. Those drugs work very
differently than memantine does. They delay the breakdown of a brain
chemical called acetylcholine, which is needed for nerve cells to
communicate.
Memantine, in contrast, blocks excess amounts of another brain chemical,
glutamate, which can damage or kill nerve cells.
About four million Americans have Alzheimer's disease, and one million
are believed to suffer severe symptoms.
|
|
